Patients with chronic obstructive pulmonary disease: analysis of actual clinical practice

Chronic obstructive pulmonary disease (COPD) remains a disease whose global prevalence is not decreasing, and mortality is increasing. Over the past 10 years, the position of the global initiative GOLD classification and treatment COPD three times changed. The aim of the work is to assess the distribution of COPD patients according to different criteria, peculiarities of their treatment and adherence to treatment. Material and methods. 125 patients with COPD in hospital - 123 (98.4%) men and 2 (1.6%) women with an average age of 64.9±0.7 (8.2) years were examined. All patients underwent physical examination, a survey on standardized questionnaires CAT and mMRC and spirography. Results. According to GOLD 2007 classification, patients were distributed as follows: GOLD I - 6.4%, GOLD II - 29.6%, GOLD III - 43.2%, GOLD IV - 20.8%. According to the ABCD GOLD 2011 classification, 4% of patients were classified as type C and 96% as type D, and 3.2, 11.2, 0.8 and 84.8%, respectively, in ABCD GOLD 2017 redistribution. Such factors as hospitalization, changed the distribution of the patients according to groups ABCD. Among the respondents 93.6% received short - acting bronchodilators, 63.2% - long-acting bronchodilators, inhalation steroids with long-acting bronchodilators - 58.4%. 27,2% of patients were completely complementary, 72.8% of patients were well trained by the medical worker to correct use of the inhaler. Patients among all drugs preferred short-acting bronchodilators and dosing aerosol inhalers, would like to use them only on demand. The worst time of the day the majority of patients called morning. Conclusion. The study reflects the dynamism in the diagnosis and treatment of COPD, the change of priorities from clinical physiology to anamnetic data. Identified key areas that will improve the quality of treatment of patients with COPD in the studied region - the increased commitment of physicians national clinical guidelines and improving patient adherence to doctor's prescriptions.

chronic obstructive pulmonary disease, treatment, clinical recommendations, therapeutic cooperation